Abeona Therapeutics (ABEO) Cash from Operations (2011 - 2026)

Abeona Therapeutics' Cash from Operations history runs 16 years deep, the most recent figure standing at 19804000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 7.62% year-over-year to 19804000.0; the TTM figure through Mar 2026 stood at 77728000.0 (down 29.81% YoY), while the FY2025 annual figure was 76326000.0, down 36.26% from the prior year.
• Cash from Operations was 19804000.0 for Q1 2026 at Abeona Therapeutics, down from 17953000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 5746000.0 in Q3 2023 to a low of 21187000.0 in Q3 2025.
• Historically, Cash from Operations has averaged 13684529.41 across 5 years, with a median of 13687000.0 in 2022.
• The sharpest annual moves came in 2022 and 2024: Cash from Operations soared 53.76% in 2022, then sank 112.91% in 2024.
• A 5-year view of Cash from Operations shows it stood at 13992000.0 in 2022, then jumped by 34.0% to 9235000.0 in 2023, then sank by 79.31% to 16559000.0 in 2024, then slipped by 8.42% to 17953000.0 in 2025, then retreated by 10.31% to 19804000.0 in 2026.
• The last three Cash from Operations figures came in at 19804000.0 (Q1 2026), 17953000.0 (Q4 2025), and 21187000.0 (Q3 2025), per Business Quant data.